Quintiles and London Genetics will offer pharmacogenetics solutions to the biopharma industry after collaborating to help advance personalised medicine.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at Penn Pharma, Omnicare, TranScrip Partners and Selvita.
Pfizer has welcomed Government commitments to keep Ireland’s 12.5 per cent corporation tax rate in face of recent EU pressure to increase it as a condition of the €85bn 7-year IMF bailout.
GlaxoSmithKline will sell its oral penicillin manufacturing facility in Tennessee, US, to Dr Reddy’s for an undisclosed sum, along with US rights to its Augmentin and Amoxin brands.
SGS Life Sciences will expand bioanalytical capacity at its facility in Poitiers, France in the latest stage of its effort to become the biggest biologics testing services firm by 2014.
Camlin Fine Chemicals has been given the green light from its board of directors to acquire an unnamed Italian fine chemicals manufacturer and form a subsidiary company to help boost its presence in the Middle East.
ACTA was finalised last week but controversies remain, with research warning it could “create significant barriers to international trade, especially in generic medicines”.
Dalton Pharma Services and Lonza are teaming up to provide clients with a range of chemistry services, from discovery through to commercial production of active pharmaceutical ingredients (APIs).
Rumours suggest that Genzyme would consider accepting lower value takeover bids that take into account future performance of its cancer drug Campath in MS indications.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Euthymics, CytomX, NPS Pharmaceuticals and InQ Biosciences.
Novartis aims to focus on the development of specialty medicines in a new long-term strategy to boost profitability in a rapidly changing healthcare environment.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at INC, Perceptive, Althea, Novella and BioClinica.
Last week everything from co-processed excipients to Viagra-stuffed teddies were discussed at AAPS 2010. Now, with the show having finished, we present our personal take on the event.
Roche will cut 4,800 jobs worldwide over the next two years as part of a restructuring program designed to slash $2.4bn Swiss francs ($2.4bn) from annual costs.
IMS Health predicts China will become the world’s second largest pharmaceutical market by 2015 due to robust economic growth and healthcare reforms that allow for increased spending on drugs.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at Premier Research, Porsolt and BioStorage.
Clinical Research Advantage (CRA) is introducing its services to the Las Vegas market by opening eight new offices in the region to help trial sponsors bring drugs to market quicker and more effectively.
Clinical software developer, Forte Research Systems, has opened a new office in Bangalore, India, to take advantage of growth in the clinical research industry on the sub-continent.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Aqua Pharmaceuticals, Algeta ASA and Amarin.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including the departure of an FDA foreign inspections official and the search for a leader of the EMA.
Dutch biopharmaceutical company Crucell expects its operating loss for 2010 to be in the €20-25 million range, citing costs associated with microbial contamination at its Shingal facility in Korea as a key factor.
Novartis is teaming up with Arab Company for Pharmaceutical Products (Arabio) to provide Saudi Arabia and surrounding regions with vaccines for common diseases.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at Parexel, Catalent, AMRI, BioStorage and BRANY.
Quintiles and Dako, a Danish-based cancer diagnostics firm, are teaming up to help speed development of personalised medicine by collaborating on the co-development of targeted oncology therapies and diagnostics.
Biopharm are increasingly assessing the threat counterfeiting and diversion pose to emerging biotechs when planning an acquisition, according to a white paper.
Pfizer has widen its recall of the cholesterol-fighting drug, Lipitor, after two more complaints of a musty odour emanating from the product’s bottles.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at INC Research, Emerald BioStructures and ClinOps.
Overseas FDA offices have realised immediate benefits but strategic planning is needed to ensure the ventures, critical aspects of the agency’s ability to ensure drug quality, are long-term successes according to the GAO.
UK-drugmaker GlaxoSmithKline (GSK) must pay $750m to settle a law suit criticising manufacturing practices at plant in Cidra, Puerto Rico that was shut down in 2009.
Parexel Consulting has released its annual analysis of FDA new drug review trends, which indicates there is a “new normal” emerging in the drug review and approval process.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Jennerex, a new KV subsidiary and Takeda.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at Trident, Agilux and Clinical Trials of America.